Drimva

GSK

ViiV Healthcare (GSK) Marketing Director, Long-Acting HIV Treatment – U.S. Launch Lead

USA - North Carolina - Durham · Hybrid (Remote & On-site) · Director · Full-time · Posted Oct 5, 2026

Experience
8+ years of commercial marketing experience, including 3+ years of people management experience; commercial launch-phase or growth-phase brand experience required.
Education
Bachelor’s degree; advanced degree (MBA or equivalent postgraduate qualification) preferred.

About the job

Leads U.S. commercialization strategy and launch execution for ViiV’s next-generation long-acting HIV treatment, coordinating cross-functional teams and marketing investment.

What you'll do

  • Define and lead the end-to-end U.S. launch and brand strategy, including positioning, customer strategy, messaging, and HCP campaigns.
  • Drive cross-functional launch readiness and collaborate with field teams, agencies, and external stakeholders to optimize execution.
  • Lead financial planning, investment allocation, ROI assessment, and launch performance measurement.

What they ask for

  • Bachelor’s degree and 8+ years of commercial marketing experience within pharmaceutical or biotechnology organizations, including 3+ years of people management experience.
  • Commercial experience leading launch phase or growth phase for pharmaceutical brands.
  • Proven experience working cross-functionally with Medical, Regulatory, and Market Access teams.
  • Demonstrated ability to use data and insights to inform strategic marketing decisions.

Nice to have

  • Advanced degree (MBA or equivalent postgraduate qualification); experience in HIV treatment and/or long-acting therapies in the U.S. market.
  • Expertise in the U.S. pharmaceutical commercial environment, implementation models, field execution, or AI / advanced analytics for commercial decisions.

Tools

AI, advanced analytics

AI focus

Preferred use of AI / advanced analytics to drive commercial decisions.

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 6, 2026 (UTC)